vimarsana.com
Home
Live Updates
Lupin stock climbs nearly 4% on launch of Mirabegron Extende
Lupin stock climbs nearly 4% on launch of Mirabegron Extende
Lupin stock climbs nearly 4% on launch of Mirabegron Extended-Release tablets in US
Mirabegron Extended-Release tablets had estimated annual sales of $1,019 million in the US
Related Keywords
Mumbai ,
Maharashtra ,
India ,
United States ,
South Africa ,
America ,
Asia Pacific ,
Lupin Ltd ,
Astellas Pharma Global Development Inc ,
Drug Administration ,
Mirabegron Extended Release ,
Myrbetriq Extended Release ,
Astellas Pharma Global Development ,
Active Pharmaceutical Ingredients ,
Latin America ,
Lupin ,
Lupin Share Price ,
Upin Stock Price ,
Mirabegron Extended Release Tablets ,
S Fda ,